Cassava Sciences | PTIE - Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 18.38B 1.88B 2026-03
Amgen USD 25.5B 547M 2026-06
Biogen USD 3.92B 918.2M 2026-06
Cara Therapeutics USD 11.26M 216K 2026-03
Cassava Sciences USD 40.11M 3.72M 2026-03
Eisai JPY 393.64B 53.39B 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Geron USD 70.33M 3.24M 2026-06
J&J USD 54.9B 2.82B 2026-06
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Novavax USD 330.57M 11.89M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Roche Holding CHF 28.85B 846M 2026-06